药物对比
Dapagliflozin vs Repaglinide
比较 Dapagliflozin（Farxiga）与 Repaglinide 治疗2型糖尿病：SGLT2与格列奈类在心脏/肾脏获益、低血糖风险、体重和给药方面的差异。
此页面暂无可用的对比维度。
临床背景
Triggered when adding second-line oral therapy after metformin or switching due to cardiovascular/renal disease, hypoglycemia risk or meal-related dosing needs in type 2 diabetes.
结论
Dapagliflozin is generally preferred for most patients owing to proven heart and kidney benefits plus a safer hypoglycemia profile, though Repaglinide can fit cost-sensitive cases needing prandial flexibility without those comorbidities.
全部药物对比